EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T‐cell associations in diffuse large B‐cell lymphoma

Jenny Coelho iD, Sophia M Roush, Alexander M Xu, Kaushik Puranam, Marriam Mponda, Edwards Kasonkanji iD, Maurice Mulenga, Tamiwe Tomoka, Jonathan Galeotti, Amy Brownlee, Hormas Ghadially, Blossom Damania und 4 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Jenny Coelho und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina (UNC), Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, HIV Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of lymphoma worldwide, accounting for up to 40% of new non‐Hodgkin Lymphoma (NHL) globally. People living with HIV are up to 17 times more likely to develop NHL, and as such, DLBCL is the leading cause of cancer death in this high‐risk population. While histologically indistinguishable, HIV‐associated (HIV+) and HIV‐negative (HIV−) DLBCL are molecularly distinct, and biological differences may have implications for the development of future therapeutic interventions. Further, the impact of immunologic differences in people with HIV, including preceding ART, remains largely unknown. Here, we investigate the impact of HIV infection and ART exposure on the clinical features of DLBCL and T‐cell immune response by performing imaging mass cytometry on our unique patient cohort in Malawi. In this cohort, HIV infection is positively prognostic, and HIV+/ART‐naïve patients have the best outcomes. No established biomarkers other than Ki67 are associated with HIV or ART status, and the only tumour‐intrinsic biomarkers that remain prognostic are MYC and MYC/BCL2 protein co‐expression. Finally, TCR clonality is associated with distinct tumour‐T cell interactions by HIV/ART status, indicating differential anti‐tumour immune responses. We demonstrate previously undescribed HIV and ART‐related differences in the DLBCL tumour microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseHIV InfectionsHumansMaleFemaleAdultMiddle AgedT-LymphocytesAnti-Retroviral Agents

Stichwörter der Autor:innen

HIVT cell receptor repertoirenon‐Hodgkin lymphomatumour biology

Substanzen

Anti-Retroviral Agents

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina (UNC), Chapel Hill, North Carolina, USA.
  • Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • UNC Project Malawi, Lilongwe, Malawi.
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
  • Department of Pathology, School of Medicine and Oral Health, Kamuzu University of Health Sciences, Lilongwe, Malawi.
  • Department of Microbiology and Immunology, School of Medicine, UNC, Chapel Hill, North Carolina, USA.

ORCID-Profile: Jenny Coelho, Edwards Kasonkanji, Yuri Fedoriw

Förderung

  • NCI NIH HHS
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
  • NCATS NIH HHS
  • NIGMS NIH HHS
  • FIC NIH HHS
  • Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill
  • Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine
  • National Institute of General Medical Sciences

Zitieren

APA

Coelho, J., Roush, S. M., Xu, A. M., Puranam, K., Mponda, M., Kasonkanji, E., Mulenga, M., Tomoka, T., Galeotti, J., Brownlee, A., Ghadially, H., Damania, B., Painschab, M., Merchant, A., Gopal, S., & Fedoriw, Y. (2024). HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T‐cell associations in diffuse large B‐cell lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.19531

Vancouver

Coelho J, Roush SM, Xu AM, Puranam K, Mponda M, Kasonkanji E, et al. HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T‐cell associations in diffuse large B‐cell lymphoma. British Journal of Haematology. 2024. doi:10.1111/bjh.19531

BibTeX
@article{Coelho2024,
  author = {Coelho, Jenny and Roush, Sophia M and Xu, Alexander M and Puranam, Kaushik and Mponda, Marriam and Kasonkanji, Edwards and Mulenga, Maurice and Tomoka, Tamiwe and Galeotti, Jonathan and Brownlee, Amy and Ghadially, Hormas and Damania, Blossom and Painschab, Matthew and Merchant, Akil and Gopal, Satish and Fedoriw, Yuri},
  title = {HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T‐cell associations in diffuse large B‐cell lymphoma},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19531}
}
Kostenlos starten →